Suchergebnisse - "Payne, Christopher D"

PubPharm (5)

1

Effect of age on the pharmacokinetics and pharmacodynamics of prasugrel during multiple dosing : an open-label, single-sequence, clinical trial

enthalten in: Drugs & aging | 2009

von Small, D. | Wrishko, R. | Ernest, C. | +6

2

Switching directly to prasugrel from clopidogrel results in greater inhibition of platelet aggregation in aspirin-treated subjects

enthalten in: Platelets | 2008

von Payne, C. | Li, Y. | Brandt, J. | +5

3

The use of the VerifyNow P2Y12 point-of-care device to monitor platelet function across a range of P2Y12 inhibition levels following prasugrel and clopidogrel administration

enthalten in: Thrombosis and haemostasis | 2008

von Jakubowski, J. | Payne, C. | Li, Y. | +5

4

Dose-dependent inhibition of human platelet aggregation by prasugrel and its interaction with aspirin in healthy subjects

enthalten in: Journal of cardiovascular pharmacology | 2007

von Jakubowski, J. | Payne, C. | Weerakkody, G. | +6

5

Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease

enthalten in: European heart journal | 2006

von Jernberg, T. | Payne, C. | Winters, K. | +6

CommentIn: Eur Heart J. 2006 Aug;27(15):1886-7; author reply 1887-8. - PMID 16801327

1
[1]